These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
116 related items for PubMed ID: 7591242
41. Antiproliferative and synergistic effect of interferon alpha-2a, retinoids and their association in established human cancer cell lines. Toma S, Monteghirfo S, Tasso P, Nicolò G, Spadini N, Palumbo R, Molina F. Cancer Lett; 1994 Jul 29; 82(2):209-16. PubMed ID: 8050093 [Abstract] [Full Text] [Related]
43. Glutathione related enzymes in cis-diamminedichloroplatinum (II)-sensitive and-resistant human ovarian carcinoma cells. Oguchi H, Kikkawa F, Kojima M, Maeda O, Mizuno K, Suganuma N, Kawai M, Tomoda Y. Anticancer Res; 1994 Jul 29; 14(1A):193-200. PubMed ID: 7909418 [Abstract] [Full Text] [Related]
44. Modulation of sensitivity to cis-diamminedichloroplatinum (II) by thromboxane A2 receptor antagonists in non-small-cell lung cancer cell lines. Kasahara K, Fujimura M, Bando T, Shibata K, Shirasaki H, Matsuda T. Br J Cancer; 1996 Nov 29; 74(10):1553-8. PubMed ID: 8932334 [Abstract] [Full Text] [Related]
45. Effect of hyperthermia on cis-diamminedichloroplatinum(II) (rhodamine 123)2[tetrachloroplatinum(II)] in a human squamous cell carcinoma line and a cis-diamminedichloroplatinum(II)-resistant subline. Herman TS, Teicher BA, Cathcart KN, Kaufmann ME, Lee JB, Lee MH. Cancer Res; 1988 Sep 15; 48(18):5101-5. PubMed ID: 3409235 [Abstract] [Full Text] [Related]
47. Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system. Light BW, Yu WD, McElwain MC, Russell DM, Trump DL, Johnson CS. Cancer Res; 1997 Sep 01; 57(17):3759-64. PubMed ID: 9288784 [Abstract] [Full Text] [Related]
48. [Cross-resistance to radiation in human squamous cell carcinoma cells with induced cisplatin resistance]. Komori K. Kokubyo Gakkai Zasshi; 1998 Jun 01; 65(2):202-12. PubMed ID: 9711039 [Abstract] [Full Text] [Related]
49. [Up-regulation of human chorionic gonadotropin alpha subunit gene and human mitochondrial cytochrome c oxidase subunit II gene in cis-Diamminedichloroplatinum(II)-resistant human head and neck squamous carcinoma cells]. Higuchi E. Hokkaido Igaku Zasshi; 1999 May 01; 74(3):231-8. PubMed ID: 10422566 [Abstract] [Full Text] [Related]
50. Synergistic antiproliferative activity of suramin and alpha 2A-interferon against human colorectal adenocarcinoma cell lines: in vitro studies. Falcone A, Danesi R, Zaccaro L, Pieracci D, Pfanner E, Cianci C, Andreuccetti M, Malvaldi G, Del Tacca M, Conte PF. Eur J Cancer; 1994 May 01; 30A(4):516-20. PubMed ID: 8018411 [Abstract] [Full Text] [Related]
51. Establishment and characterization of a cisplatin-resistant human neuroblastoma cell line. Yasuno T, Matsumura T, Shikata T, Inazawa J, Sakabe T, Tsuchida S, Takahata T, Miyairi S, Naganuma A, Sawada T. Anticancer Res; 1999 May 01; 19(5B):4049-57. PubMed ID: 10628353 [Abstract] [Full Text] [Related]
52. Relationship between expression of drug-resistance factors and drug sensitivity in normal human renal proximal tubular epithelial cells in comparison with renal cell carcinoma. Asakura T, Imai A, Ohkubo-Uraoka N, Kuroda M, Iidaka Y, Uchida K, Shibasaki T, Ohkawa K. Oncol Rep; 2005 Sep 01; 14(3):601-7. PubMed ID: 16077962 [Abstract] [Full Text] [Related]
53. Intracellular uptake of an antitumor-active azole-bridged dinuclear platinum(II) complex in cisplatin-resistant tumor cells. Kishimoto S, Yasuda M, Suzuki R, Fukushima S. Biometals; 2016 Dec 01; 29(6):1075-1083. PubMed ID: 27787693 [Abstract] [Full Text] [Related]
54. Sensitization of human renal cell carcinoma cells to cis-diamminedichloroplatinum(II) by anti-interleukin 6 monoclonal antibody or anti-interleukin 6 receptor monoclonal antibody. Mizutani Y, Bonavida B, Koishihara Y, Akamatsu K, Ohsugi Y, Yoshida O. Cancer Res; 1995 Feb 01; 55(3):590-6. PubMed ID: 7834629 [Abstract] [Full Text] [Related]
55. Synergistic interaction between cisplatin and tamoxifen delays the emergence of cisplatin resistance in head and neck cancer cell lines. Nakata B, Albright KD, Barton RM, Howell SB, Los G. Cancer Chemother Pharmacol; 1995 Feb 01; 35(6):511-8. PubMed ID: 7882460 [Abstract] [Full Text] [Related]
56. Modulation of p53 expression by human recombinant interferon-alpha2a correlates with abrogation of cisplatin resistance in a human melanoma cell line. Davol PA, Goulette FA, Frackelton AR, Darnowski JW. Cancer Res; 1996 Jun 01; 56(11):2522-6. PubMed ID: 8653690 [Abstract] [Full Text] [Related]
57. The relationship of the human glutathione S-transferase P1 polymorphism and chemotherapeutic sensitivity in head and neck squamous carcinoma. Kimura S, Imagawa Y, Satake K, Tsukuda M. Int J Mol Med; 2004 Aug 01; 14(2):185-9. PubMed ID: 15254763 [Abstract] [Full Text] [Related]
58. Effect of buthionine sulfoximine on PtII and PtIV drug accumulation and the formation of glutathione conjugates in human ovarian-carcinoma cell lines. Mistry P, Loh SY, Kelland LR, Harrap KR. Int J Cancer; 1993 Nov 11; 55(5):848-56. PubMed ID: 8244583 [Abstract] [Full Text] [Related]
59. Establishment of a cisplatin-resistant gastric carcinoma cell line OCUM-2M/DDP. Nitta A, Chung YS, Nakata B, Yashiro M, Onoda N, Maeda K, Sawada T, Sowa M. Cancer Chemother Pharmacol; 1997 Nov 11; 40(1):94-7. PubMed ID: 9137537 [Abstract] [Full Text] [Related]
60. Chemosensitivity of head and neck squamous carcinoma cell lines is not primarily correlated with glutathione level but is modified by glutathione depletion. Bier H, Hoffmann T, Eickelmann P, Hafner D. J Cancer Res Clin Oncol; 1996 Nov 11; 122(11):653-8. PubMed ID: 8898974 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]